TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody

Acta Derm Venereol. 2013 Nov;93(6):715-6. doi: 10.2340/00015555-1550.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Autoantibodies / blood*
  • Carcinoma / blood
  • Carcinoma / chemistry
  • Carcinoma / immunology*
  • Carcinoma / secondary
  • Carcinoma / surgery
  • Dermatomyositis / blood
  • Dermatomyositis / drug therapy
  • Dermatomyositis / immunology*
  • Endometrial Neoplasms / blood
  • Endometrial Neoplasms / chemistry
  • Endometrial Neoplasms / immunology*
  • Endometrial Neoplasms / pathology
  • Endometrial Neoplasms / surgery
  • Female
  • Humans
  • Hysterectomy
  • Middle Aged
  • Paraneoplastic Syndromes / blood
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / immunology*
  • Prednisolone / therapeutic use
  • Transcription Factors / immunology*
  • Treatment Outcome
  • Up-Regulation

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • TRIM33 protein, human
  • Transcription Factors
  • Prednisolone